Reference
Sakamoto H, et al. Characteristics of central nervous system progression in non-small cell lung cancer treated with crizotinib or alectinib. Cancer Reports 4: 1-8, No. 6, Dec 2021. Available from: URL: http://doi.org/10.1002/cnr2.1414
Rights and permissions
About this article
Cite this article
Alectinib/crizotinib. Reactions Weekly 1937, 26 (2022). https://doi.org/10.1007/s40278-022-29706-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-29706-7